Open Access

Intelligent Healthcare Systems Powered by Large Language Models: Applications, Limitations, and Emerging Research Perspectives

4 Department of Computer Science, West African Institute of Technology, Lagos, Nigeria

Abstract

Large language models (LLMs) are increasingly being incorporated into healthcare systems to support clinical communication, medical reasoning, information synthesis, patient interaction, documentation, and emerging forms of predictive analytics. Their adoption introduces a significant shift from conventional task-specific artificial intelligence toward general-purpose language-based systems capable of processing heterogeneous clinical information. However, the usefulness of these systems depends not only on linguistic performance but also on factual reliability, clinical fidelity, transparency, confidentiality, evaluation methodology, and regulatory suitability. This paper presents a structured review and analytical framework for understanding intelligent healthcare systems powered by LLMs, based exclusively on the provided literature. The analysis examines major application domains, including clinical decision support, patient-facing communication, clinical summarization, diagnostic reasoning, health trajectory forecasting, and digital-twin-oriented systems. Particular attention is given to the discrepancy between apparent model capability and clinically meaningful performance. The literature indicates that LLMs can provide substantial value in information-intensive healthcare workflows, but hallucinations, inconsistent reasoning, evaluation limitations, privacy concerns, and regulatory uncertainty constrain their safe deployment. The paper proposes a lifecycle-oriented perspective in which LLM-based healthcare systems should be evaluated through task-specific clinical benchmarks, human oversight, safety monitoring, confidentiality controls, and regulatory alignment. The findings position LLMs as augmentation technologies rather than autonomous replacements for healthcare professionals and identify research priorities involving robust evaluation, clinically grounded reasoning, patient safety, and trustworthy system architectures.

Keywords

References

Agrawal M, Chen IY, Gulamali F, Joshi S. The evaluation illusion of large language models in medicine. npj Digit Med. 2025;8:600.
Bedi S, Jiang Y, Chung P, Koyejo S, Shah N. Fidelity of medical reasoning in large language models. JAMA Netw Open. 2025;8(8):e2526021.
Clusmann J, Kolbinger FR, Muti HS, Carrero ZI, Eckardt JN, Laleh NG, et al. The future landscape of large language models in medicine. Commun Med. 2023;3:141.
Communications Medicine Editorial/Review corpus on patient-facing LLMs and limitations—see Truhn et al. 2025 systematic review for taxonomy of design/output risks. Commun Med. 2025;5:26.
Goh E, Gallo R, Hom J, et al. Large language model influence on diagnostic reasoning: a randomized clinical trial. JAMA Netw Open. 2024;7(10):e2440969.
Hatem R, Simmons B, Thornton JE. A call to address AI “hallucinations” and how healthcare professionals can mitigate their risks. Cureus. 2023;15(9):e44720.
Jo E, Zhang C, Thomas MR, et al. Assessing GPT-4’s performance in delivering medical advice using realworld user-generated queries. JMIR Med Educ. 2024;10(1):e51282.
Johri S, Jeong J, Tran BA, Schlessinger DI, Wongvibulsin S, Barnes LA, et al. An evaluation framework for clinical use of large language models in patient interaction tasks. Nat Med. 2025;31:77-86.
Maity S, Bhattacharjee A, Sharma A. Large language models in healthcare and medical applications: opportunities, challenges, and future directions. Bioengineering. 2025;12(6):631.
Makarov N, Bordukova M, Quengdaeng P, et al. Large language models forecast patient health trajectories enabling digital twins. npj Digit Med. 2025;8:588.
Perlis RH, Fihn SD. Editorial context on evaluation standards and confidentiality when using LLMs with clinical data. JAMA Netw Open. 2023;6(10):e2335924.
Truhn D, Cuocolo R, Adams LC, et al. Current applications and challenges in large language models for patient care: a systematic review. Commun Med. 2025;5:26.
US Food and Drug Administration (FDA). Artificial Intelligence and Machine Learning Software as a Medical Device. Updated Mar 25, 2025. fda.gov.

Most read articles by the same author(s)

1 2 3 4 5 6 > >> 

Similar Articles

31-40 of 56

You may also start an advanced similarity search for this article.